[1] GIULIANO A E, KIRGAN D M, GUENTHER J M, et al. Lymphatic mapping and sentinel lymphadenectomy for breast cancer [J]. Ann Surg, 1994, 220(3): 391-8; discussion 8-401.
[2] VERONESI U, PAGANELLI G, VIALE G, et al. Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series [J]. J Natl Cancer Inst, 1999, 91(4): 368-73.
[3] ALBERTINI J J, LYMAN G H, COX C, et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer [J]. JAMA, 1996, 276(22): 1818-22.
[4] VERONESI U, PAGANELLI G, GALIMBERTI V, et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes [J]. Lancet, 1997, 349(9069): 1864-7.
[5] KRAG D, WEAVER D, ASHIKAGA T, et al. The sentinel node in breast cancer--a multicenter validation study [J]. N Engl J Med, 1998, 339(14): 941-6.
[6] GIULIANO A E, MCCALL L, BEITSCH P, et al. Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial [J]. Ann Surg, 2010, 252(3): 426-32; discussion 32-3.
[7] LYMAN G H, TEMIN S, EDGE S B, et al. Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update [J]. J Clin Oncol, 2014, 32(13): 1365-83.
[8] GRADISHAR W J, ANDERSON B O, BLAIR S L, et al.Breast cancer version 3.2014 [J]. J Natl Compr Canc Netw, 2014, 12(4): 542-90.
[9] CAUDLE A S, HUNT K K, TUCKER S L, et al. American College of Surgeons Oncology Group (ACOSOG) Z0011: impact on surgeon practice patterns [J]. Ann Surg Oncol, 2012, 19(10): 3144-51.
[10] LOVELAND-JONES C E, RUTH K, SIGURDSON E R, et al. Patterns of nodal staging during breast conservation surgery in the medicare patient: will the ACOSOG Z0011 trial change the pattern of care?有涉及ECI [J]. Breast Cancer Res Treat, 2014, 143(3): 571-7.
[11] LIU M, WANG S, CUI S, et al. The feasibility of the ACOSOG Z0011 Criteria to Chinese Breast Cancer Patients: A Multicenter Study [J]. Sci Rep, 2015, 5(15241.
[12] LEE Y C, WU C T, KUO S W, et al. Significance of extranodal extension of regional lymph nodes in surgically resected non-small cell lung cancer [J]. Chest, 2007, 131(4): 993-9.
[13] AN Y, PARK H S, KELLY J R, et al. The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinoma [J]. Cancer, 2017, 123(14): 2762-72.
[14] KIM C W, KIM J, YEOM S S, et al. Extranodal extension status is a powerful prognostic factor in stage III colorectal cancer [J]. Oncotarget, 2017, 8(37): 61393-403.
[15] JIANYONG L, JINJING Z, ZHIHUI L, et al. A Nomogram Based on the Characteristics of Metastatic Lymph Nodes to Predict Papillary Thyroid Carcinoma Recurrence [J]. Thyroid, 2018, 28(3): 301-10.
[16] KIM C W, KIM J, PARK Y, et al. Prognostic Implications of Extranodal Extension in Relation to Colorectal Cancer Location
[J]. Cancer Res Treat, 2018,
[17] AI Q Y, KING A D, POON D M C, et al. Extranodal extension is a criterion for poor outcome in patients with metastatic nodes from cancer of the nasopharynx [J]. Oral Oncol, 2019, 88(124-30.
[18] BILLFALK-KELLY A, YU E, SU J, et al. Radiologic Extranodal Extension Portends Worse Outcome in cN+ TNM8 Stage I Human Papillomavirus-Mediated Oropharyngeal Cancer [J]. Int J Radiat Oncol Biol Phys, 2019,
[19] MARKS P, GILD P, SOAVE A, et al. The impact of variant histological differentiation on extranodal extension and survival in node positive bladder cancer treated with radical cystectomy [J]. Surg Oncol, 2019, 28(208-13.
[20] RIVERS A K, GRIFFITH K A, HUNT K K, et al. Clinicopathologic features associated with having four or more metastatic axillary nodes in breast cancer patients with a positive sentinel lymph node [J]. Ann Surg Oncol, 2006, 13(1): 36-44.
[21] CIL T, HAUSPY J, KAHN H, et al. Factors affecting axillary lymph node retrieval and assessment in breast cancer patients [J]. Ann Surg Oncol, 2008, 15(12): 3361-8.
[22] FUJII T, YANAGITA Y, FUJISAWA T, et al. Implication of extracapsular invasion of sentinel lymph nodes in breast cancer: prediction of nonsentinel lymph node metastasis [J]. World J Surg, 2010, 34(3): 544-8.
[23] KWON Y, RO J, KANG H S, et al. Clinicopathological parameters and biological markers predicting non-sentinel node metastasis in sentinel node-positive breast cancer patients [J]. Oncol Rep, 2011, 25(4): 1063-71.
[24] MITTENDORF E A, HUNT K K, BOUGHEY J C, et al. Incorporation of sentinel lymph node metastasis size into a nomogram predicting nonsentinel lymph node involvement in breast cancer patients with a positive sentinel lymph node [J]. Ann Surg, 2012, 255(1): 109-15.
[25] CHOI A H, BLOUNT S, PEREZ M N, et al. Size of Extranodal Extension on Sentinel Lymph Node Dissection in the American College of Surgeons Oncology Group Z0011 Trial Era [J]. JAMA Surg, 2015, 150(12): 1141-8.
[26] EDGE S B, COMPTON C C. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM [J]. Ann Surg Oncol, 2010, 17(6): 1471-4.
[27] TEVIS S E, BASSETT R, BEDROSIAN I, et al. OncotypeDX Recurrence Score Does Not Predict Nodal Burden in Clinically Node Negative Breast Cancer Patients [J]. Ann Surg Oncol, 2019, 26(3): 815-20.
[28] FAJKOVIC H, CHA E K, JELDRES C, et al. Extranodal extension is a powerful prognostic factor in bladder cancer patients with lymph node metastasis [J]. Eur Urol, 2013, 64(5): 837-45.
[29] LEE I S, PARK Y S, RYU M H, et al. Impact of extranodal extension on prognosis in lymph node-positive gastric cancer [J]. Br J Surg, 2014, 101(12): 1576-84.
[30] WU M H, SHEN W T, GOSNELL J, et al. Prognostic significance of extranodal extension of regional lymph node metastasis in papillary thyroid cancer [J]. Head Neck, 2015, 37(9): 1336-43.
[31] SAKAI M, SUZUKI S, SANO A, et al. Significance of lymph node capsular invasion in esophageal squamous cell carcinoma [J]. Ann Surg Oncol, 2012, 19(6): 1911-7.
[32] AMIN M B, GREENE F L, EDGE S B, et al. The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more "personalized" approach to cancer staging [J]. CA Cancer J Clin, 2017, 67(2): 93-9.
[33] LYDIATT W M, PATEL S G, O'SULLIVAN B, et al. Head and Neck cancers-major changes in the American Joint Committee on cancer eighth edition cancer staging manual [J]. CA Cancer J Clin, 2017, 67(2): 122-37.
[34] WEAVER D L. Pathology evaluation of sentinel lymph nodes in breast cancer: protocol recommendations and rationale [J]. Mod Pathol, 2010, 23 Suppl 2(S26-32.
[35] GIULIANO A E, EDGE S B, HORTOBAGYI G N. Eighth Edition of the AJCC Cancer Staging Manual: Breast Cancer [J]. Ann Surg Oncol, 2018, 25(7): 1783-5.
[36] O'KEEFFE N A, O'NEILL C, ZAHERE A, et al. A quantitative analysis of tumour characteristics in breast cancer patients with extranodal extension in non-sentinel nodes [J]. Breast, 2018, 38(171-4.
[37] SIVRIDIS E, GIATROMANOLAKI A, GALAZIOS G, et al. Node-related factors and survival in node-positive breast carcinomas [J]. Breast, 2006, 15(3): 382-9.
[38] STRANZL H, OFNER P, PEINTINGER F. Postoperative irradiation in breast cancer patients with one to three positive axillary lymph nodes. Is there an impact of axillary extranodal tumor extension on locoregional and distant control? [J]. Strahlenther Onkol, 2006, 182(10): 583-8.
[39] GOOCH J, KING T A, EATON A, et al. The extent of extracapsular extension may influence the need for axillary lymph node dissection in patients with T1-T2 breast cancer [J]. Ann Surg Oncol, 2014, 21(9): 2897-903.
[40] SHIGEMATSU H, TAGUCHI K, KOUI H, et al. Clinical Significance of Extracapsular Invasion at Sentinel Lymph Nodes in Breast Cancer Patients with Sentinel Lymph Node Involvement [J]. Ann Surg Oncol, 2015, 22(7): 2365-71.
[41] CHANGSRI C, PRAKASH S, SANDWEISS L, et al. Prediction of additional axillary metastasis of breast cancer following sentinel lymph node surgery [J]. Breast J, 2004, 10(5): 392-7.
[42] JOSEPH K A, EL-TAMER M, KOMENAKA I, et al. Predictors of nonsentinel node metastasis in patients with breast cancer after sentinel node metastasis [J]. Arch Surg, 2004, 139(6): 648-51.
[43] KATZ A, SMITH B L, GOLSHAN M, et al. Nomogram for the prediction of having four or more involved nodes for sentinel lymph node-positive breast cancer [J]. J Clin Oncol, 2008, 26(13): 2093-8.
[44] SCHWENTNER L, DAYAN D, WOCKEL A, et al. Is extracapsular nodal extension in sentinel nodes a predictor for nonsentinel metastasis and is there an impact on survival parameters?-A retrospective single center cohort study with 324 patients [J]. Breast J, 2018, 24(4): 480-6.
[45] NOTTEGAR A, VERONESE N, SENTHIL M, et al. Extra-nodal extension of sentinel lymph node metastasis is a marker of poor prognosis in breast cancer patients: A systematic review and an exploratory meta-analysis [J]. Eur J Surg Oncol, 2016, 42(7): 919-25.
[46] CHOI A H, SURRUSCO M, RODRIGUEZ S, et al. Extranodal extension on sentinel lymph node dissection: why should we treat it differently? [J]. Am Surg, 2014, 80(10): 932-5.
[47] VANE M L G, WILLEMSEN M A, VAN ROOZENDAAL L M, et al. Extracapsular extension in the positive sentinel lymph node: a marker of poor prognosis in cT1-2N0 breast cancer patients? [J]. Breast Cancer Res Treat, 2019, 174(3): 711-8.
[48] AZIZ S, WIK E, KNUTSVIK G, et al. Extra-nodal extension is a significant prognostic factor in lymph node positive breast cancer [J]. PLoS One, 2017, 12(2): e0171853.